Skip to main content

Bian, Jiang

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #202
  • Rising Star
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Public Health

NIH Funding · FY2023

Linked Award Amount
$10.8M
Full award amounts, FY2023
Award Records
8
Records listing this PI
Award-Linked Rank
#202
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Bian, Jiang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Bian, Jiang as a PI. Multi-PI records show the full award amount for context.

  • 1RF1AG084178-01RF1Contact PI
    Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
    $2.6M
    award amount
  • 1RF1AG077820-01A1RF1Contact PI
    AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods
    $2.3M
    award amount
  • 5U01TR003709-02U01Contact PI
    PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases
    $1.2M
    award amount
  • 1R01AG083039-01R01Contact PI
    An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records
    $1.2M
    award amount
  • 1R01AG084236-01R01Contact PI
    ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
    $1.2M
    award amount
  • 1R01AG080991-01R01Contact PI
    Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI
    Weill Cornell Medicine · Public Health (NIH department code)
    $820.2K
    award amount
  • 5R01AG076234-02R01Contact PI
    Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
    Weill Cornell Medicine · Public Health (NIH department code)
    $775.2K
    award amount
  • 1R01AI172875-01A1R01Contact PI
    Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)
    University of Florida · Public Health (NIH department code)
    $731.4K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2019
    First NIH Award
    University of Pennsylvania
  2. 2020
    Multi-Institutional Research
    Awards at 5 institutions
  3. 2020
    R01 Grant Holder
  4. 2021
    $500K Cumulative Funding
  5. 2021
    $1M Cumulative Funding
  6. 2021
    $2M Cumulative Funding
  7. 2021
    Entered Top 50% Nationally
    Ranked #4793
  8. 2021
    Entered Top 25% Nationally
    Ranked #4793
  9. 2021
    Program/Center Grant Leader
  10. 2023
    $5M Cumulative Funding
  11. 2023
    $10M Cumulative Funding
  12. 2023
    Entered Top 10% Nationally
    Ranked #202
  13. 2023
    Entered Top 5% Nationally
    Ranked #202